DongKook Pharmaceutical Co. Ltd Cash Flow Conversion Efficiency

Latest as of June 2026: 0.040x

DongKook Pharmaceutical Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, DongKook Pharmaceutical Co. Ltd (086450) has a cash flow conversion efficiency ratio of 0.040x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩32.26 Billion ≈ $21.86 Million USD) by net assets (₩797.63 Billion ≈ $540.54 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of DongKook Pharmaceutical Co. Ltd (2013–2025)

Cash flow conversion efficiency of DongKook Pharmaceutical Co. Ltd from 2013 to 2025. This chart illustrates how DongKook Pharmaceutical Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest DongKook Pharmaceutical Co. Ltd stock price today for real-time trading data and today's change.

DongKook Pharmaceutical Co. Ltd Cash Flow Conversion Ratio Explained

DongKook Pharmaceutical Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

DongKook Pharmaceutical Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of DongKook Pharmaceutical Co. Ltd ranked by their cash flow conversion efficiency. Also see 086450 stock market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Espey Mfg & Electronics Corp NYSE MKT:ESP	0.112x
GOLFZON Co. Ltd KQ:215000	0.052x
Jean Co Ltd TW:2442	-0.131x
Sang-A Frontec Co.Ltd KQ:089980	0.026x
Bossa Ticaret ve Sanayi Isletmeleri TAS IS:BOSSA	0.024x
GRIGEO AB EO -29 F:WM8	0.033x
Indo Borax & Chemicals Limited NSE:INDOBORAX	0.114x
Mammoth Energy Services Inc NASDAQ:TUSK	-0.010x

Annual Cash Flow Conversion Efficiency for DongKook Pharmaceutical Co. Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of DongKook Pharmaceutical Co. Ltd from 2013 to 2025. Review 086450 FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩763.74 Billion ≈ $517.57 Million	₩68.76 Billion ≈ $46.60 Million	0.090x	-19.66%
2024-12-31	₩678.98 Billion ≈ $460.13 Million	₩76.09 Billion ≈ $51.57 Million	0.112x	+54.50%
2023-12-31	₩576.17 Billion ≈ $390.46 Million	₩41.79 Billion ≈ $28.32 Million	0.073x	-11.00%
2022-12-31	₩501.94 Billion ≈ $340.16 Million	₩40.91 Billion ≈ $27.72 Million	0.082x	-17.03%
2021-12-31	₩454.57 Billion ≈ $308.05 Million	₩44.65 Billion ≈ $30.26 Million	0.098x	-31.63%
2020-12-31	₩411.37 Billion ≈ $278.78 Million	₩59.11 Billion ≈ $40.06 Million	0.144x	-24.96%
2019-12-31	₩362.87 Billion ≈ $245.91 Million	₩69.48 Billion ≈ $47.09 Million	0.191x	+80.48%
2018-12-31	₩313.02 Billion ≈ $212.13 Million	₩33.21 Billion ≈ $22.51 Million	0.106x	-2.29%
2017-12-31	₩263.94 Billion ≈ $178.87 Million	₩28.66 Billion ≈ $19.42 Million	0.109x	-34.62%
2016-12-31	₩237.32 Billion ≈ $160.83 Million	₩39.41 Billion ≈ $26.71 Million	0.166x	+22.14%
2015-12-31	₩199.62 Billion ≈ $135.28 Million	₩27.14 Billion ≈ $18.39 Million	0.136x	+5.59%
2014-12-31	₩176.57 Billion ≈ $119.66 Million	₩22.74 Billion ≈ $15.41 Million	0.129x	+5.20%
2013-12-31	₩162.24 Billion ≈ $109.95 Million	₩19.86 Billion ≈ $13.46 Million	0.122x	--

About DongKook Pharmaceutical Co. Ltd

KQ:086450 Korea Pharmaceuticals

Market Cap

$140.87 Million

₩207.88 Billion KRW

Market Cap Rank

#17708 Global

#752 in Korea

Share Price

₩23650.00

Change (1 day)

+0.85%

52-Week Range

₩16420.00 - ₩29900.00

All Time High

₩31498.93